These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ocular penetration of grepafloxacin after intravitreal administration in albino and pigmented rabbits. Solans C; Bregante MA; Garcia MA; Perez S Chemotherapy; 2004 Jun; 50(3):133-7. PubMed ID: 15282440 [TBL] [Abstract][Full Text] [Related]
6. Penetration of prulifloxacin into gynaecological tissues after single and repeated oral administrations. Gorlero F; Lorenzi P; Rosignoli MT; Picollo R; Ruggieri A; Barattè S; Dionisio P Drugs R D; 2007; 8(6):373-81. PubMed ID: 17963428 [TBL] [Abstract][Full Text] [Related]
7. Flomoxef sodium and levofloxacin concentrations in aqueous humor. Mizuki N; Watanabe Y; Miyamoto M; Iijima Y; Takiyama N; Ito Y; Ito N; Nishida T; Iwata S; Endo Y; Ito D Ocul Immunol Inflamm; 2005; 13(2-3):229-34. PubMed ID: 16019684 [TBL] [Abstract][Full Text] [Related]
8. [Diffusion of fluoroquinolones in the aqueous humor and crystalline lens]. Lafaix C; Salvanet A; Fisch A; Forestier F; Montay G; Meulemans A Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):768-71. PubMed ID: 3309812 [TBL] [Abstract][Full Text] [Related]
9. Poor penetration of cefcapene into aqueous humor after oral administration of cefcapene pivoxil to patients undergoing cataract surgery. Okamoto K; Asano S; Yamamoto T; Toyono T; Yamaguchi R; Okada Y; Okugawa S; Suzuki H; Moriya K; Aihara M J Infect Chemother; 2020 Feb; 26(2):312-315. PubMed ID: 31481306 [TBL] [Abstract][Full Text] [Related]
10. Determination of ulifloxacin, the active metabolite of prulifloxacin, in human plasma by a 96-well format solid-phase extraction and capillary zone electrophoresis. Zhang L; Wen J; Pan Y; Li Z; Fan G; Wu Y J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):172-6. PubMed ID: 18706872 [TBL] [Abstract][Full Text] [Related]
11. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216 [TBL] [Abstract][Full Text] [Related]
12. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry. Guo L; Qi M; Jin X; Wang P; Zhao H J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):280-5. PubMed ID: 16490405 [TBL] [Abstract][Full Text] [Related]
13. Correlation among the toxicity profiling (28-days repeated oral dose toxicity), toxicokinetics and tissue distribution data of ulifloxacin, the active metabolite of prulifloxacin in Wistar albino rats. Nandi U; Roy B; Das AK; Pal TK Environ Toxicol Pharmacol; 2012 Sep; 34(2):588-607. PubMed ID: 22885677 [TBL] [Abstract][Full Text] [Related]
14. [Anti-inflammatory effects and aqueous humor concentration of various nonsteroidal anti-inflammatory drugs in extracapsular cataract surgery]. Hessemer V; Schmitt K; Jacobi A Klin Monbl Augenheilkd; 1996 Mar; 208(3):161-6. PubMed ID: 8699774 [TBL] [Abstract][Full Text] [Related]
15. Penetration of orally administered prulifloxacin into human lung tissue. Concia E; Allegranzi B; Ciottoli GB; Orticelli G; Marchetti M; Dionisio P Clin Pharmacokinet; 2005; 44(12):1287-94. PubMed ID: 16372826 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography. Pellegrino RM; Segoloni F; Cagini C J Pharm Biomed Anal; 2008 Jul; 47(3):567-74. PubMed ID: 18339505 [TBL] [Abstract][Full Text] [Related]
17. Penetration of prulifloxacin into sinus mucosa of patients undergoing paranasal sinus elective endoscopic surgery. De Benedetto M; Passali D; Tomacelli G; Ruggieri A; Rosignoli MT; Picollo R; Bellussi L; Dionisio P J Chemother; 2012 Feb; 24(1):26-31. PubMed ID: 22546721 [TBL] [Abstract][Full Text] [Related]
18. New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment. Tellone V; Coppola P; Ammendola M; Di Loreto G; Picollo R; Del Vecchio A; Comandini A; Garofolo F; Tongiani S Drugs R D; 2018 Sep; 18(3):237-245. PubMed ID: 30151791 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerability of prulifloxacin after single oral administration. Picollo R; Brion N; Gualano V; Millérioux L; Marchetti M; Rosignoli MT; Dionisio P Arzneimittelforschung; 2003; 53(3):201-5. PubMed ID: 12705176 [TBL] [Abstract][Full Text] [Related]
20. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]